Seawoods Pharmaceuticals Private Limited

Seawoods Pharmaceuticals Private Limited - pharma in Delhi, India. FY 2026 financials & compliance.
CIN U24232DL2005PTC132079 Incorporated 13 January 2005 ROC Delhi HQ Delhi, India
Active Private Limited Company pharma
Revenue · FY 2025
₹2.81 Lakh
▲ 6% YoY
Net loss · FY 2025
₹37,131
Net margin -13.2%
EBITDA · FY 2025
-₹36,901
EBITDA margin -13.1%
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹2 Lakh
Issued & subscribed
Company age
21 yrs
Est. 2005
Directors on board
2
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Seawoods Pharmaceuticals Private Limited

Data last updated:

Seawoods Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 13 January 2005 and has been in existence for over 21 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2005PTC132079.

The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Meenakshi Tandon and Ravindra Tandon.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at S – 10 Csc – 10 Sector 3 Rohini, Delhi, India – 110085.

As per the financials filed for FY 2025, the company reported a revenue of ₹2.81 Lakh, a growth of 6% compared to the previous year. For the same year it recorded a net loss of ₹37,131 (net margin -13.2%) and EBITDA of -₹36,901 (EBITDA margin -13.1%). Revenue has declined at a compounded annual rate (CAGR) of 9% over three years and 4% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232DL2005PTC132079
Registration Number 132079
Incorporation Date 13 January 2005
ROC Delhi
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Seawoods Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    S – 10 Csc – 10 Sector 3 Rohini, Delhi, India – 110085
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors

To see the full contact details of Seawoods Pharmaceuticals Private Limited, buy the company report.

Comprehensive company report
Seawoods Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Seawoods Pharmaceuticals is trade. In detail, this covers retail trading.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
GTradeG2Retail Trading

To see the full business activity and turnover split of Seawoods Pharmaceuticals Private Limited, buy the company report.

Financials of Seawoods Pharmaceuticals Private Limited

FY 2025 filings available

Seawoods Pharmaceuticals Private Limited reported revenue of ₹2.81 Lakh (up 6% YoY) for FY 2025.

Revenue · FY 2025
₹2.81 Lakh ▲ 6%
Net loss · FY 2025
₹37,131 margin -13.2%
EBITDA · FY 2025
-₹36,901 margin -13.1%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 6%
3 years · compounded
▲ 9%
5 years · compounded
▼ 4%
EBITDA CAGR growth
1 year
▼ 18%
3 years · compounded
▼ 20%
5 years · compounded
▼ 18%

Revenue rose 6% in the latest year, though over five years it has declined at a compounded annual rate (CAGR) of 4%. EBITDA fell 18% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹36,901
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹37,131
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin-13.1%
Net Profit Margin-13.2%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Seawoods Pharmaceuticals Private Limited, buy the company report.

Board of directors of Seawoods Pharmaceuticals Private Limited

Seawoods Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Meenakshi TandonDirector01 Oct 201511 Years 1 MonthsCurrent
Ravindra TandonDirector13 Jan 200521 Years 10 MonthsCurrent

Auditor

Seawoods Pharmaceuticals Private Limited is audited by J N SHARMA & CO for the financial year 2017.

Auditor firmFinancial yearFirm registration number
J N SHARMA & COFY 2017000833C

Shareholding

The shareholding of Seawoods Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Seawoods Pharmaceuticals Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Seawoods Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

No GST registration is on our record for Seawoods Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.

Recent activity

Seawoods Pharmaceuticals Private Limited has 4 board changes on record since 2005: 2 appointments and 2 cessations. The latest: Meenakshi Tandon ceased to be Additional Director on 30 Sep 2016.

AGM
Seawoods Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Seawoods Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi Ii.
Ceased
Meenakshi Tandon ceased to be Additional Director.
Ceased
Deepak Tandon ceased to be Director.
Appointed
Meenakshi Tandon was appointed as Director.
Appointed
Ravindra Tandon was appointed as Director.
Incorporation
13 Jan 2005
Seawoods Pharmaceuticals Private Limited was registered on 13 Jan 2005 with Roc Delhi Ii & aged 21 years 10 months as per MCA records.

Frequently asked questions

Seawoods Pharmaceuticals is an active private limited company based in Delhi, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 13 January 2005 (21+ years old) and is registered under CIN U24232DL2005PTC132079.

Seawoods Pharmaceuticals has 2 current directors:

The latest financial statements of Seawoods Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The CIN (Corporate Identification Number) of Seawoods Pharmaceuticals is U24232DL2005PTC132079. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Seawoods Pharmaceuticals was incorporated on 13 January 2005, making it 21+ years old. It is registered with the Registrar of Companies, Delhi.

Meenakshi Tandon ceased to be Additional Director on 30 Sep 2016. Deepak Tandon ceased to be Director on 01 Nov 2015. Meenakshi Tandon was appointed as Director on 01 Oct 2015. Seawoods Pharmaceuticals has 4 board changes on record in total.

The registered office of Seawoods Pharmaceuticals is at S – 10 Csc – 10 Sector 3 Rohini, Delhi, India – 110085.

Seawoods Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

The compliance status of Seawoods Pharmaceuticals is compliant as of 22 August 2026. The company is actively filing with the Registrar of Companies.

Seawoods Pharmaceuticals can be reached at its registered office: S – 10 Csc – 10 Sector 3 Rohini, Delhi, India – 110085.